For: | da Mota VHS, Freire de Melo F, de Brito BB, Silva FAFD, Teixeira KN. Molecular docking of DS-3032B, a mouse double minute 2 enzyme antagonist with potential for oncology treatment development. World J Clin Oncol 2022; 13(6): 496-504 [PMID: 35949428 DOI: 10.5306/wjco.v13.i6.496] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v13/i6/496.htm |
Number | Citing Articles |
1 |
Karolina I. Pellot Ortiz, Julian S. Rechberger, Leo F. Nonnenbroich, David J. Daniels, Jann N. Sarkaria. MDM2 Inhibition in the Treatment of Glioblastoma: From Concept to Clinical Investigation. Biomedicines 2023; 11(7): 1879 doi: 10.3390/biomedicines11071879
|
2 |
Ishaar P. Ganesan, Hiroaki Kiyokawa. A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins. Cancers 2025; 17(4): 626 doi: 10.3390/cancers17040626
|
3 |
Jerson L. Silva, Debora Foguel, Vitor F. Ferreira, Tuane C. R. G. Vieira, Mayra A. Marques, Giulia D. S. Ferretti, Tiago F. Outeiro, Yraima Cordeiro, Guilherme A. P. de Oliveira. Targeting Biomolecular Condensation and Protein Aggregation against Cancer. Chemical Reviews 2023; 123(14): 9094 doi: 10.1021/acs.chemrev.3c00131
|
4 |
Hiroyuki Takeda, Hiroyuki Yamamoto, Ritsuko Oikawa, Kumiko Umemoto, Hiroyuki Arai, Takuro Mizukami, Kazuki Ogawa, Yoshiyasu Uchida, Yusuke Nagata, Yohei Kubota, Ayako Doi, Yoshiki Horie, Takashi Ogura, Naoki Izawa, Jay A. Moore, Ethan S. Sokol, Yu Sunakawa. Genomic Profiling of Small Intestine Cancers From a Real-World Data Set Identifies Subgroups With Actionable Alterations. JCO Precision Oncology 2024; (8) doi: 10.1200/PO.23.00425
|